Giuffre Randall Michael 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Common Stock
2026-01-02$8.42/sh+6,175$51,994→ 398,587 total
Holdings
- 25,573(indirect: See footnote)
Common Stock
- 21,070(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.
- [F2]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.